ArticleInternational journal of pharmaceutics: X2026
Biomimetic co-delivery nanoplatform overcomes CAF- and TAM-induced immunosuppression to augment therapeutic efficacy against triple-negative breast cancer.
Haiwang Luo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.